20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Managing Acromegaly: The Role of Octreotide Acetate and Other Treatments

Acromegaly is a chronic hormonal disorder that arises from an overproduction of growth hormone (GH) by the pituitary gland, typically due to a benign tumor. This excess GH leads to the enlargement of bones in the hands, feet, and face, along with other health complications. Managing Acromegaly effectively often involves a multi-faceted approach, with Octreotide Acetate playing a significant role.

The journey to manage Acromegaly often begins with diagnosing the condition, which involves blood tests to measure GH and Insulin-like Growth Factor 1 (IGF-1) levels, and imaging studies like MRI to locate pituitary tumors. Once diagnosed, treatment aims to normalize hormone levels and alleviate symptoms. Surgical removal of the pituitary tumor is often the first line of treatment. However, when surgery is not fully successful or for patients who cannot undergo surgery, medical therapy becomes essential. This is where Octreotide Acetate, a crucial pharmaceutical intermediate, comes into play.

Octreotide Acetate works by mimicking the action of somatostatin, a natural hormone that inhibits GH release. By administering Octreotide Acetate, patients experience a reduction in GH and IGF-1 levels, which helps to control the physical manifestations of Acromegaly, such as enlarged hands and feet, and reduce the risk of complications like diabetes and heart disease. The ability to buy Octreotide Acetate online has made it more accessible for patients and clinicians managing this complex condition.

Other treatment options for Acromegaly include other somatostatin analogs, dopamine agonists, and growth hormone receptor antagonists. Radiation therapy may also be used in certain cases. NINGBO INNO PHARMCHEM CO.,LTD. supplies high-quality Octreotide Acetate, supporting the therapeutic arsenal against Acromegaly. It is vital for patients to work closely with their endocrinologists to determine the most effective treatment plan, which may involve a combination of therapies. Understanding the potential side effects of Octreotide Acetate and adhering to prescribed treatment regimens are paramount for successful management.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Science Behind Octreotide Acetate: Mechanisms and Therapeutic Applications

Next: Octreotide Acetate in the Treatment of Neuroendocrine Tumors: A Clinical Perspective

All Rights Reserved